Sun Pharma Inds. Stock Price Analysis and Quick Research Report. Is Sun Pharma Inds. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Sun Pharma Inds.. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Sun Pharma Inds. has a PE ratio of 79.0555338873721 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Sun Pharma Inds. has ROA of 9.8789% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Sun Pharma Inds. has a Current ratio of 1.0276.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Sun Pharma Inds. has a ROE of 17.8315%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Sun Pharma Inds. has a Debt to Equity ratio of 0.4501 which means that the company has low proportion of debt in its capital.

• Sales growth: Sun Pharma Inds. has reported revenue growth of 13.4557% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Sun Pharma Inds. for the current financial year is 28.4223197250137%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Sun Pharma Inds. is Rs 16 and the yield is 1.0128%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Sun Pharma Inds. is Rs 19.9986. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Sun Pharma Inds. in Ticker for free. Also, one can get the intrinsic value of Sun Pharma Inds. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Sun Pharma Inds. FAQs

Q1. What is Sun Pharma Inds. share price today?
Ans: The current share price of Sun Pharma Inds. is Rs 1581.

Q2. What is the market capitalisation of Sun Pharma Inds.?
Ans: Sun Pharma Inds. has a market capitalisation of Rs 379334.858757 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Sun Pharma Inds.?
Ans: The PE ratio of Sun Pharma Inds. is 79.0555338873721 and the P/B ratio of Sun Pharma Inds. is 15.1169339301064, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Sun Pharma Inds. share?
Ans: The 52-week high share price of Sun Pharma Inds. is Rs 1960.35, and the 52-week low share price of Sun Pharma Inds. is Rs 1553.05.

Q5. Does Sun Pharma Inds. pay dividends?
Ans: Currently, Sun Pharma Inds. pays dividends. Dividend yield of Sun Pharma Inds. is around 1.0128%.

Q6. What are the face value and book value of Sun Pharma Inds. shares?
Ans: The face value of Sun Pharma Inds. shares is Rs 1, while the book value per share of Sun Pharma Inds. is around Rs 104.5847. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Sun Pharma Inds.?
Ans: Sun Pharma Inds. has a total debt of Rs 10954.47 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Sun Pharma Inds.?
Ans: The ROE of Sun Pharma Inds. is 17.8315% and ROCE of Sun Pharma Inds. is 16.9165%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Sun Pharma Inds. a good buy for the long term?
Ans: The Sun Pharma Inds. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Sun Pharma Inds. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Sun Pharma Inds. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Sun Pharma Inds.’s financials?
Ans: You can review Sun Pharma Inds.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.